東華科技(002140.SZ):與關聯方等聯合投建中泰崇左產業園新材料標準廠房一期及排污配套基礎設施PPP項目
格隆匯12月20日丨東華科技(002140.SZ)公佈,公司與中國化學工程第四建設有限公司(“中化四建”)、浙江海拓環境技術有限公司(“浙江海拓”)組成的聯合體(即社會資本方)中標了中泰崇左產業園新材料標準廠房一期及排污配套基礎設施PPP項目(簡稱“該PPP項目”)。
根據社會資本方與廣西崇左市城市工業投資發展集團有限公司(“工投集團”)達成的《股東投資合作協議》,各方將按照相應比例共同組建項目公司,並由項目公司負責建設、運營該PPP項目。該PPP項目總投資約為人民幣4.568億元,項目資本金為人民幣9282.08萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.